Citi upgrades Hims & Hers Health (HIMS.US) rating to "Neutral", optimistic about compliance premium under Novo Nordisk agreement

老虎证券2026/03/10 08:34

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This adjustment is mainly based on a key agreement recently reached between the company and Novo Nordisk (NVO.US): by acting as an agent to sell Novo Nordisk's GLP-1 drugs for weight loss and type 2 diabetes treatment, Hims & Hers Health has significantly reduced a variety of business risks previously concerning the market, including core issues such as product pipeline singularity, market competition pressure, and compliance uncertainties.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Citi upgrades Hims & Hers Health (HIMS.US) rating to "Neutral", optimistic about compliance premium under Novo Nordisk agreement

You may also like

Crypto prices